Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceMice, Inbred C57BLCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionTreatment OutcomeHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidStem Cell TransplantationImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseSevere Combined ImmunodeficiencyColony-Forming Units AssayT-LymphocytesChimeraHLA AntigensMyelodysplastic SyndromesSurvival AnalysisRetrospective StudiesLung TransplantationCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionCell DifferentiationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectFollow-Up StudiesGraft vs Leukemia EffectCytarabineLeukocyte CountSurvival RateCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMice, Inbred BALB CMelphalanDisease-Free SurvivalFlow CytometryEtoposideCells, CulturedLymphomaMultiple MyelomaFatal OutcomeMice, KnockoutAntigens, CD34Hodgkin DiseaseCell TransplantationPrognosisGranulocytesInfectionCord Blood Stem Cell Transplantation